TCL Archive Letter to the Editor: NCI Should Continue Supporting Research In Special Populations July 31, 1998
TCL Archive President Asks $600 Million For NCI In ’75; Research Grants Would Get $19 Million Hike February 8, 1974
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
